Global Vaccine Partnering Terms & Agreements Report 2010-2016: Analysis, Deal Trends, Technologies & Forecasts - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials" report to their offering.

The Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials report provides comprehensive access to available deals and contract documents for over 880 vaccine deals, including:

  • Trends in vaccine and adjuvant partnering deals
  • Deal terms analysis
  • Partnering agreement structure
  • Partnering contract documents
  • Top deals by value
  • Most active dealmakers
  • Average deal terms for vaccines

This report contains a comprehensive listing of all vaccine partnering deals announced since January 2010, including financial terms where available, including over 1,000 links to online deal records of actual vaccine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Key Topics Covered:

  • In-depth understanding of vaccine and adjuvant deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of vaccine agreements with numerous real life case studies
  • Comprehensive access to over 1,000 actual vaccine deals entered into by the world's biopharma companies, together with contract documents if available
  • Detailed access to actual vaccine contracts enter into by leading bio pharma companies
  • Identify leading vaccine deals by value since 2010
  • Identify the most active vaccine dealmakers since 2010
  • Insight into the terms included in a vaccine agreement, together with real world clause examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report Structure:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Vaccines dealmaking

Chapter 3 - Leading Vaccines deals

Chapter 4 - Most active Vaccines dealmakers

Chapter 5 - Vaccines contracts dealmaking directory

Chapter 6 - Vaccines dealmaking by technology type

Chapter 7 - Partnering resource center

Appendices

For more information about this report visit http://www.researchandmarkets.com/research/9pwfk9/global_vaccine

Related Topics: Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716